IMPLEMENTATION LEVEL

National

AFFECTED FLOW

Inflow

ANNOUNCED AS TEMPORARY

No

NON-TRADE-RELATED RATIONALE

No

ELIGIBLE FIRMS

firm-specific

JUMBO

No

TARIFF PEAK

No
← back to the state act
Inception date: 25 Apr 2018 | Removal date: open ended
Still in force

Financial grant

On April 25, 2018 Minister of Innovation, Science and Economic Development Navdeep Bains announced a Can.$22.5 million (U.S.$17.3 million) investment in biotechnology company STEMCELL Technologies to build a state-of-the-art manufacturing facility. This funding will support the development of regenerative medicine products certified for use in clinical trials, the construction of a $138-million state-of-the-art manufacturing facility by 2022, and the eventual consolidation of three of STEMCELL’s Vancouver locations into a single campus in Burnaby, British Columbia.

AFFECTED COUNTRIES

MAP
TABLE
EXPORT

AFFECTED SECTORS AND PRODUCTS

352 Pharmaceutical products
3002 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micr
300210 Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes

Please report this page in case you detect an inaccuracy in its content.